{"id":"https://genegraph.clinicalgenome.org/r/7eac7f97-5922-44ac-bc81-b1537f9e97b0v1.0","type":"EvidenceStrengthAssertion","dc:description":"CD247 was first reported in relation to autosomal recessive immunodeficiency 25 in 2006 (Rieux-Laucat et al., PMID: 16672702). Immunodeficiency 25 is a T-B+NK+ severe combined immunodeficiency (SCID). Three variants (nonsense, initiator codon, and extension) that have been reported in 3 probands in 3 publications (PMIDs: 16672702, 27555457, 17170122) are included in this curation. Affected individuals typically present in infancy with severe, recurrent infections; low T cell counts; and impaired T cell proliferation. The production of autoantibodies has been described (PMID: 16672702); however, evidence for symptomatic autoimmunity is currently lacking. Multiple probands have been identified with somatic reversion in which spontaneously arising somatic mutations recover protein expression (PMID: 16672702, 27555457). Heterozygous carriers are reported as unaffected (PMID: 27555457). The mechanism of pathogenicity appears to be loss of function.\n\nThis gene-disease association is supported by expression studies, protein interactions, functional assays, and animal models (PMIDs: 18853439, 31461748, 1717999, 27555457, 8223444, 8223445). CD247 is expressed in lymphoid tissues and encodes the zeta chain of the T-cell receptor (TCR) complex (PMID: 18853439). The TCR is made up of multiple other CD3 chains including gamma (CD3G gene) and epsilon (CD3E gene) (PMID: 31461748). Extracellular stimulation of the TCR phosphorylates the intracellular zeta chain, and the phosphorylated zeta chain binds a zeta chain associated protein kinase 70 (ZAP70 gene) to initiate downstream signaling (PMID: 1717999). We have previously established that these three genes; CD3E, CD3G, and ZAP70; are definitively associated with severe combined immunodeficiency. Impaired TCR-induced signaling including impaired ZAP70 phosphorylation has also been observed in human T cells that have a CD247 homozygous loss of function variant (PMID: 27555457). CD247 knockout mice have T cell lymphocytopenia and reduced T cell proliferation consistent with SCID (PMID: 8223444, 8223445).\n\nIn summary, CD247 is definitively associated with autosomal recessive immunodeficiency 25. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen SCID/CID GCEP on February 17, 2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/7eac7f97-5922-44ac-bc81-b1537f9e97b0","GCISnapshot":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-03-11T14:12:01.618Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-03-11T14:05:52.812Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6cd47df-b997-4243-bb31-f3fd5be56e80","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae3089b6-3bd7-4a85-b166-d43148fad044","type":"Finding","dc:description":"Homozygous mice had considerably reduced T cells in spleen, lymph nodes, and blood. (Figure 7, Table II) Splenic T cells from knockout mice displayed a reduced proliferation upon stimulation with lectin or an anti-CD3E mAb. (Figure 9) This is consistent with the human phenotype--SCID is characterized by T cell lymphocytopenia and impaired proliferation. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8223445","rdfs:label":"Ohno Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/48e02549-6662-4c42-aea3-412a2dde8555","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d73defe6-fd97-43a7-b473-e037d3ec78b5","type":"Finding","dc:description":"The knock out mice thymuses contained 2- to 30- fold less cells than wt or hets. (Figure 2) Knock out mice thymuses showed only minute amounts of TCR complexes on T cell surfaces. (Figure 6)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8223444","rdfs:label":"Malissen mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2adaabc3-9aba-415f-a0aa-d752c15c33c6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df927ec6-75b1-46a6-8ff2-ad854c753b67","type":"FunctionalAlteration","dc:description":"Patient T cells showed extremely reduced surface TCR expression as compared to controls. Heterozygous family members' cells showed an intermediate surface TCR expression level. (Fig. 1B) CD3-zeta is known to regulate the assembly of the TCR and its expression on the cell surface. \nPatient T cells also showed impaired TCR-induced signaling including CD69 upregulation, short term proliferation of primary T cells, and ZAP-70 and extracellular signal regulated kinase (ERK) phosphorylation. Cells of a heterozygous family member showed intermediate levels of signaling. (Fig. 2A,B,C) The TCR including CD3-zeta is responsible for transmitting signals across the cell membrane.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27555457","rdfs:label":"TCR Expression and Function in Patient and Het Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8a5afed-d7b2-4e99-8d3b-f66ff05afcfb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3c3548e-e3a0-4d5c-a19a-26b8aa1cc429","type":"Finding","dc:description":"Jurkat cells were stimulated with SED in the presence of Raji cells, which serve as the antigen-presenting cells. In SED-stimulated cells, ZAP-70 (arrowhead) co-precipitates with CD3 zeta. (Fig. 1B, lane 4) We have previously demonstrated that ZAP70 is associated with severe combined immunodeficiency (definitive level of evidence).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1717999","rdfs:label":"ZAP70 Association with TCR Stimulation","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/34530c49-d11f-4c2a-9fc9-88399db35d4e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4703cba-03ce-49ab-8eec-e1e11ea4d604","type":"Finding","dc:description":"Cryo-electron microscopy is used to visualize the T cell receptor-CD3 complex. This complex is made up of CD3-gamma (CD3G), -delta (CD3D), -epsilon (CD3E), and -zeta proteins, and we have previously associated CD3E and CD3G with severe combined immunodeficiency (definitive level of evidence).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31461748","rdfs:label":"T cell receptor-CD3 complex","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c52f7523-51c6-4431-8522-247370d51da8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ae120b0-2084-4033-9c25-c8c2526d10a7","type":"Finding","dc:description":"The Human Protein Atlas reports CD247 expression in lymphoid tissues including thymus, lymph node, bone marrow, and spleen. This supports the role of this gene in immunodeficiency. Within the blood and bone marrow, T cells show the highest expression, consistent with the T-B+NK+ SCID phenotype of the condition.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18853439","rdfs:label":"Lymphoid Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/438b6c1f-edc0-4a81-9c82-39627e5a69cd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8f82c6c-dd38-42b8-8582-570604379e2f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4dd535a-ccb0-4584-99d4-f7a5d284738d","type":"EvidenceLine","dc:description":"c.412dup (p.His138ProfsTer136) is absent in gAD. Note that this is an extension variant, so each variant received a downgrade from the standard predicted or proven null variant score (1.5>1.0pt). However, each variant was also upgraded given the functional evidence available (1.0>1.5pt).","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4dd535a-ccb0-4584-99d4-f7a5d284738d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"MA5.8 cells transduced with the variant did not express detectable CD3zeta and failed to assemble complete TCR complexes. (Figure 7)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e4dd535a-ccb0-4584-99d4-f7a5d284738d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17170122","allele":{"id":"https://genegraph.clinicalgenome.org/r/b08470c2-d70c-4b91-916d-57fdbafebb5b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198053.3(CD247):c.412dup (p.His138ProfsTer136)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573049024"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/e8f82c6c-dd38-42b8-8582-570604379e2f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17170122","rdfs:label":"Roberts proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b08470c2-d70c-4b91-916d-57fdbafebb5b"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"T-B+NK+ SCID\nSalmonella gastroenteritis","phenotypes":["obo:HP_0001873","obo:HP_0001508","obo:HP_0005403","obo:HP_0031692","obo:HP_0000403","obo:HP_0030253","obo:HP_0012735","obo:HP_0000988"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4dd535a-ccb0-4584-99d4-f7a5d284738d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a8080ef4-4b26-4d7d-a521-2fea5186df99_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5427afb8-c3db-4726-9292-f046b104f843","type":"EvidenceLine","dc:description":"c.58+8C>T is present in gAD, with 26 alleles (no homozygotes). Given this variant 1. does not affect the consensus splice site, 2. does not have any supporting functional data, and 3. has only weak information connecting it to the phenotype, I am not scoring this variant.","calculatedScore":0.2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5427afb8-c3db-4726-9292-f046b104f843_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26915675","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4b298b1-8dd3-4700-acf0-91a22a90b8d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198053.3(CD247):c.58+8C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA235765"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a8080ef4-4b26-4d7d-a521-2fea5186df99","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26915675","rdfs:label":"P1257","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4b298b1-8dd3-4700-acf0-91a22a90b8d9"},"detectionMethod":"NGS panel of 162 PID genes","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"combined immunodeficiency","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5427afb8-c3db-4726-9292-f046b104f843_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/67b66f3c-2bda-4425-affb-b71f9a931a96_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2451be3-ee2d-4c27-9eaf-ba130eb40322","type":"EvidenceLine","dc:description":"c.2T>C (p.Met1Thr) is absent in gAD. Of note, somatic reversion is reported in this proband.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2451be3-ee2d-4c27-9eaf-ba130eb40322_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27555457","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5ed764b-4b6f-4ce1-b565-61da5b068f57","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198053.3(CD247):c.2T>C (p.Met1Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA174943"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/67b66f3c-2bda-4425-affb-b71f9a931a96","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27555457","rdfs:label":"Marin Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c5ed764b-4b6f-4ce1-b565-61da5b068f57"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"-Extremely low surface TCR levels\n-Flow cytometry showed normal CD3g, d, and Îµ expression but almost absolute absence of CD247.","phenotypes":["obo:HP_0032247","obo:HP_0010976","obo:HP_0002721","obo:HP_0032218","obo:HP_0005403"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c2451be3-ee2d-4c27-9eaf-ba130eb40322_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/fc114bbc-4d59-4157-a347-aeef0828acb5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49e9548f-9c84-422e-ae7d-3c90d03bd443","type":"EvidenceLine","dc:description":"c.208C>T (p.Gln70Ter) has 1 allele in gAD. Of note, somatic reversion is reported in this proband.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49e9548f-9c84-422e-ae7d-3c90d03bd443_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16672702","allele":{"id":"https://genegraph.clinicalgenome.org/r/81efa672-5f86-40fd-b3ba-c6c304d55a0a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198053.3(CD247):c.208C>T (p.Gln70Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA122676"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/fc114bbc-4d59-4157-a347-aeef0828acb5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16672702","rdfs:label":"Rieux-Laucat proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/81efa672-5f86-40fd-b3ba-c6c304d55a0a"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0025044","obo:HP_0001019","obo:HP_0030057","obo:HP_0005401","obo:HP_0010702","obo:HP_0006532","obo:HP_0001880","obo:HP_0005403","obo:HP_0004385","obo:HP_0410028"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/49e9548f-9c84-422e-ae7d-3c90d03bd443_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/fd9efae1-717e-4b6a-95ed-7ac9ef4cb56e_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/905fceac-ce42-4a2c-a58a-d22c1fec5ca9","type":"EvidenceLine","dc:description":"c.62C>T (p.Ala21Val) is absent in gAD. Given the lack of supporting functional data for this missense variant, the uncertainty surrounding which other genes have been ruled out by the NGS panel performed, and the difference in phenotype compared to the previously identified cases, we are not scoring this variant.","calculatedScore":0.2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/905fceac-ce42-4a2c-a58a-d22c1fec5ca9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33655388","allele":{"id":"https://genegraph.clinicalgenome.org/r/f42f0e60-ff99-44f5-841e-2efed4f22340","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198053.3(CD247):c.62C>T (p.Ala21Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343463082"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/fd9efae1-717e-4b6a-95ed-7ac9ef4cb56e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33655388","rdfs:label":"P1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f42f0e60-ff99-44f5-841e-2efed4f22340"},"detectionMethod":"The authors do not specify which or how many genes were included on this panel.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Evan's syndrome\nreduced intensity of CD3 on T cells\ncombined immunodeficiency","phenotypes":["obo:HP_0001873","obo:HP_0003237","obo:HP_0000980","obo:HP_0004844","obo:HP_0031398","obo:HP_0002788","obo:HP_0002716","obo:HP_0001954","obo:HP_0005404","obo:HP_0040089","obo:HP_0002851","obo:HP_0040126","obo:HP_0001744","obo:HP_0001508","obo:HP_0031545"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/905fceac-ce42-4a2c-a58a-d22c1fec5ca9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":9}],"evidenceStrength":"Definitive","sequence":4053,"specifiedBy":"GeneValidityCriteria8","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/6LJBR5v2F9E","type":"GeneValidityProposition","disease":"obo:MONDO_0012426","gene":"hgnc:1677","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_438b6c1f-edc0-4a81-9c82-39627e5a69cd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}